Vyome Holdings Inc.
Organization details
- Legal name
- Vyome Holdings Inc.
- Former names
- ReShape Lifesciences Inc. Obalon Therapeutics Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Clemente
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- HIND
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001427570
Board of directors
-
John M. Tincoff III · DirectorSince 2025
-
Mohanjit Jolly · DirectorSince 2025
-
Shiladitya Sengupta · DirectorSince 2025
-
Stanley D. Pomichter III · DirectorSince 2025
-
Venkateswarlu Nelabhotla · Director · President and CEOSince 2025
Chief executives
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 0
-96% a year in revenue
20% of the scoring weight is on file. Figures cover December 2024 – December 2025.
Director election results
Annual meeting of April 24, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.7%
-
99.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 15, 2025 | Venkateswarlu Nelabhotla Director, Officer (President and CEO) | Grant or award | +7 | — | — |
| Aug 15, 2025 | Dickey Robert IV Officer (Chief Financial Officer) | Grant or award | +762 | — | — |
| Aug 15, 2025 | Mohanjit Jolly Director | Grant or award | +454,456 | — | — |
| May 31, 2024 | STANKOVICH THOMAS Officer (Chief Financial Officer) | Open-market sale | −48 | $0.25 | $12 |
| Feb 29, 2024 | STANKOVICH THOMAS Officer (Chief Financial Officer) | Open-market sale | −43 | $0.17 | $7 |
| Dec 31, 2023 | STANKOVICH THOMAS Officer (Chief Financial Officer) | Open-market sale | −42 | $0.25 | $11 |
| Nov 30, 2023 | STANKOVICH THOMAS Officer (Chief Financial Officer) | Open-market sale | −39 | $0.23 | $9 |
| Oct 25, 2023 | STANKOVICH THOMAS Officer (Chief Financial Officer) | Open-market sale | −131 | $0.27 | $35 |
| Oct 11, 2023 | STANKOVICH THOMAS Officer (Chief Financial Officer) | Open-market sale | −39 | $0.93 | $36 |
| Sep 1, 2023 | STANKOVICH THOMAS Officer (Chief Financial Officer) | Open-market sale | −118 | $0.89 | $105 |
| Aug 24, 2023 | STANKOVICH THOMAS Officer (Chief Financial Officer) | Open-market sale | −39 | $1.42 | $55 |
| Aug 4, 2023 | STANKOVICH THOMAS Officer (Chief Financial Officer) | Open-market sale | −108 | $1.43 | $154 |
| Jul 6, 2023 | STANKOVICH THOMAS Officer (Chief Financial Officer) | Open-market sale | −106 | $1.47 | $156 |
| Jun 30, 2023 | STANKOVICH THOMAS Officer (Chief Financial Officer) | Open-market purchase | +17,702 | $1.52 | $26,907 |
| May 31, 2023 | STANKOVICH THOMAS Officer (Chief Financial Officer) | Open-market sale | −98 | $2.41 | $236 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Vyome Holdings Inc.
Who is the CEO of Vyome Holdings Inc.?
Venkateswarlu Nelabhotla has been Vyome Holdings Inc.'s President and CEO since August 2025.
How many directors are on Vyome Holdings Inc.'s board?
Vyome Holdings Inc.'s board has 5 directors: John M. Tincoff III, Mohanjit Jolly, Shiladitya Sengupta, Stanley D. Pomichter III and Venkateswarlu Nelabhotla.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="vyome-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.